Speciality: Rheumatology
Description:
A warm welcome to all the medical professionals in this memorable scientific session of JAKi and TNFi in rheumatological disorder.
The primary subject of discussion in this webinar is immunological responses in rheumatic diseases and the role of TNF alpha inhibitors and JAK inhibitors in rheumatological disorders. You will get a broader knowledge of the above mentioned topic through the real world evidence provided in this session.
The speakers Prof ( Dr ) Ved Chaturvedi, DR P D RATH, and Dr. Nilesh Nolkha has immense knowledge and experience in the field of rheumatology. In this webinar they have discussed how the TNF alpha inhibitors and JAK inhibitors play a key role in altering immune responses in rheumatological diseases.
TNF alpha inhibitor and JAK inhibitor drugs help in controlling inflammation in different conditions such as rheumatoid arthritis (RA), psoriatic arthritis, juvenile idiopathic arthritis, inflammatory bowel disease (Crohn's and ulcerative colitis), ankylosing spondylitis, and psoriasis.
Therefore, listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Survival rates for incurable larynx cancer investigated for first time
2.
findings from the measurement of disability weights in China with an emphasis on the impact of disease burden.
3.
Knowing about and avoiding bladder cancer.
4.
The risk of ovarian cancer is not increased by salpingectomy, according to JAMA.
5.
Aspirin Fails to Boost Survival in Colorectal Cancer Trial
1.
Evidence-Based Approaches in Hematology for Modern Medicine
2.
Citizen-Centered Digital Health Navigation Systems: Advancing Patient Engagement and Optimizing Healthcare Delivery
3.
Surgery for Tracheoesophageal Fistula: What to Expect Before, During, and After
4.
The Statistical Horizon of Colorectal Cancer: From Global Trends to Precision Therapies and Colorectal Cancer 2025 Forecasts
5.
Is p53 the Missing Puzzle Piece? Exploring Its Polymorphisms in Cervical Cancer Risk
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
2.
Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC
3.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
4.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
5.
Thromboprophylaxis In Medical Settings
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation